Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1375 to 1424 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fk506-binding protein 1a (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (12 kda fkbp) (fkbp-12) (immunophilin fkbp12). [source:swissprot;acc:p20071]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.542\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02187\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eyes absent homolog 3. [source:swissprot;acc:q99504]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.537\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02163\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 2 (zinc finger protein sall2) (hsal2). [source:swissprot;acc:q9y467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}}&\multirow{19}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02148\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 1378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 3 (zinc finger protein sall3) (hsall3). [source:swissprot;acc:q9bxa9]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arginine-glutamic acid dipeptide (re) repeats; atrophin 1-like; arginine glutamic acid dipeptide re repeats. [source:refseq;acc:nm\_012102]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin carboxyl-terminal hydrolase 8 (ec 3.1.2.15) (ubiquitin thiolesterase 8) (ubiquitin-specific processing protease 8) (deubiquitinating enzyme 8). [source:swissprot;acc:p40818]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rod1 regulator of differentiation 1; fission yeast differentiation regulator; regulator of differentiation (in s. pombi) 1; regulator of differentiation (in s. pombe) 1. [source:refseq;acc:nm\_005156]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polypyrimidine tract binding protein 2; neural polypyrimidine tract binding protein; ptb-like protein. [source:refseq;acc:nm\_021190]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adaptor-associated kinase 1. [source:refseq;acc:nm\_014911]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 1384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atrophin-1 (dentatorubral-pallidoluysian atrophy protein). [source:swissprot;acc:p54259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 47; hqp0256 protein. [source:refseq;acc:nm\_016355]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase activating protein 10. [source:refseq;acc:nm\_020824]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 1 (zinc finger protein sall1) (spalt-like transcription factor 1) (hsal1). [source:swissprot;acc:q9nsc2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 213.875\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sal-like protein 4 (zinc finger protein sall4). [source:swissprot;acc:q9ujq4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component beta chain) (bckdh e1-beta). [source:swissprot;acc:p21953]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.875\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ccr4-not transcription complex, subunit 4; not4 (negative regulator of transcription 4, yeast) homolog; ccr4-not transcription complex, subunit. [source:refseq;acc:nm\_013316]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol-binding clathrin assembly protein (clathrin assembly lymphoid myeloid leukemia protein). [source:swissprot;acc:q13492]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent clathrin coat assembly protein ap180 (clathrin coat associated protein ap180) (91 kda synaptosomal-associated protein). [source:swissprot;acc:o60641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.471\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent membrane-associated nucleic acid binding protein. [source:refseq;acc:nm\_018835]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.875\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polypyrimidine tract-binding protein 1 (ptb) (heterogeneous nuclear ribonucleoprotein i) (hnrnp i) (57 kda rna-binding protein pptb-1). [source:swissprot;acc:p26599]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth-arrest-specific protein 7 (gas-7). [source:swissprot;acc:o60861]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 213.876\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eyes absent homolog 1. [source:swissprot;acc:q99502]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.463\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.872\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02147\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s8. [source:swissprot;acc:p09058]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02145\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eyes absent homolog 4. [source:swissprot;acc:o95677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.449\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02144\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eyes absent homolog 2. [source:swissprot;acc:o00167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02137\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-7 (activating transcription factor 7) (transcription factor atf-a). [source:swissprot;acc:p17544]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.667\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02125\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-2 (activating transcription factor 2) (camp response element binding protein cre- bp1) (hb16). [source:swissprot;acc:p15336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02124\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent colorectal mutant cancer protein (mcc protein). [source:swissprot;acc:p23508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.329\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0212\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 184.656\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 180.823\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor 3b subunit 4 (spliceosome associated protein 49) (sap 49) (sf3b50) (pre-mrna splicing factor sf3b 49 kda subunit). [source:swissprot;acc:q15427]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 232.752\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 237.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02104\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 8 (eif3 p110) (eif3c). [source:swissprot;acc:q99613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 245.532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 240.483\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.021\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.833\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.456\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent wd repeat and fyve domain containing 1 isoform 1; phosphoinositide-binding protein sr1; wd40 and fyve domain containing 1. [source:refseq;acc:nm\_020830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 206.104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.424\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02096\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent stromal interaction molecule 1 precursor. [source:swissprot;acc:q13586]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 206.102\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 210.42\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02095\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent trap/mediator complex component trap25. [source:refseq;acc:nm\_080651]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent wd repeat- and fyve domain-containing protein 2; wd40 and fyve domain containing 2. [source:refseq;acc:nm\_052950]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 206.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.417\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase pak 4 (ec 2.7.1.-) (p21-activated kinase 4) (pak-4). [source:swissprot;acc:o96013]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 206.102\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 210.42\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent acyl-coa dehydrogenase, medium-chain specific, mitochondrial precursor (ec 1.3.99.3) (mcad). [source:swissprot;acc:p11310]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polyposis locus protein 1-like 1; likely ortholog of mouse polyposis locus protein 1-like 1. [source:refseq;acc:nm\_138393]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent stromal interaction molecule 2 precursor. [source:swissprot;acc:q9p246]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase pak 7 (ec 2.7.1.-) (p21-activated kinase 7) (pak-7) (pak-5). [source:swissprot;acc:q9p286]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 203.979\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 208.229\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02084\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neutral and basic amino acid transport protein rbat (b(0,+)-type amino acid transport protein) (nbat) (d2h). [source:swissprot;acc:q07837]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent aminoacylase-1 (ec 3.5.1.14) (n-acyl-l-amino-acid amidohydrolase) (acy-1). [source:swissprot;acc:q03154]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent acid ceramidase precursor (ec 3.5.1.23) (acylsphingosine deacylase) (n-acylsphingosine amidohydrolase) (ac) (putative 32 kda heart protein) (php32). [source:swissprot;acc:q13510]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.391\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 203.979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.229\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 221.152\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.659\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02074\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sodium/potassium-transporting atpase alpha-1 chain precursor (ec 3.6.3.9) (sodium pump 1) (na+/k+ atpase 1). [source:swissprot;acc:p05023]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.717\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.157\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02068\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/